Oracle partners AstraZeneca for AI-enabled healthcare innovation
Telix and Ekalia to develop US astatine-211 production
AbbVie's dual-targeting Crohn's disease therapy outperforms monotherapies in Phase IIa trial
Takeda trial shows ENTYVIO reduces ulcerative colitis complication risk by nearly 70%
GSK reports 61% response rate for investigational lung cancer drug
Omeros receives negative EU opinion on narsoplimab after re-examination
VibroSense Dynamics secures Thai regulatory approval for VibroSense Meter II
IBA and Framatome establish joint venture to scale up Astatine-211 production
SenderraRx receives reaccreditation in Specialty Pharmacy from ACHC
EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer
Philips-led EXIT-CVD consortium launches cardiovascular clinical studies across Europe
SciBase technology selected as primary endpoint in NIH-led skin exposure study